WHO resumes HCQ trial
Tribune News Service
New Delhi, June 4
The WHO late last night revoked the temporary pause it had ordered last week on the hydroxychloroquine arm of the ongoing solidarity trial and announced the trial to resume.
The decision followed the recommendations of Data Safety Board of the WHO that reviewed mortality trends and concluded that there was no cause to modify any arm of the solidarity trial protocol, which is underway to test four drugs for efficacy against Covid-19.
Indian scientists stood vindicated after the WHO decision as the ICMR has decided to continue using HCQ for prevention of Covid in health workers and frontline staffers.
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access.
Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Already a Member? Sign In Now
